최준용 (연세대학교 의과대학)님 | 한빛사연구자 > 한빛사

연세대학교 의과대학

CV File

감염의학

최종업데이트 2025.08.04.

A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19
- Nat. Commun., Published: 01 August 2025;16,7084(2025) | https://doi.org/10.1038/s41467-025-62423-4
- 2025-08
- 의약학
- 한빛사논문
Omicron BA.2 breakthrough infection elicits CD8+ T cell responses recognizing the spike of later Omicron subvariants
- Sci. Immunol., Jan 19 2024, 9 (91) | https://doi.org/10.1126/sciimmunol.ade6132
- 2024-01
- 의약학
- 한빛사논문
Comparing the efficacy of different methods of faecal microbiota transplantation via oral capsule, oesophagogastroduodenoscopy, colonoscopy, or gastric tube
- J. Hosp. Infect., Volume 131, Jan 2023, Pages 234-243 | https://doi.org/10.1016/j.jhin.2022.11.007
- 2023-01
- 의약학
- 한빛사논문
Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity
- Clin. Microbiol. Infect., Volume 28, Issue 10, October 2022, Pages 1390.e1-1390.e7 | https://doi.org/10.1016/j.cmi.2022.04.019
- 2022-10
- 의약학
- 한빛사논문
PD-1-expressing SARS-CoV-2-specific CD8+ T Cells Are Not Exhausted, but Functional in Patients with COVID-19
- Immunity, Available online 14 December 2020 | https://doi.org/10.1016/j.immuni.2020.12.002
- 2020-12
- 의약학
- 한빛사논문, 상위피인용논문
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19
- Sci. Immunol., 10 Jul 2020: Vol. 5, Issue 49, eabd1554 | 10.1126/sciimmunol.abd1554
- 2020-07
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기